Home › Lipoid Nephrosis › Texas
Lipoid Nephrosis clinical trials in Texas
4 studies for Lipoid Nephrosis are looking for participants at sites in Texas.
Cities in Texas
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
RecruitingPhase 2
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Prolato Clinical Research Center, Houston
- Clinical Trial Network, Houston
- Clinical Advancement Center, San Antonio
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT06466135Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.